Clinical trial

Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients

NCT04338867

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-03-01

PhasePHASE2

Study timeline

Study start (actual)2020-03-01Date precision: day

Registry last updated2020-04-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Phase II Clinical Trialunresolved

Ninety-six Histologically Confirmed NSCLC Patients With BMunresolved

Randomized 1:1 to Received TN Plus WBR or Only WBRunresolved

ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRIunresolved

Interventions

Whole-brain radiotherapyRADIATION

Sponsors & collaborators

Instituto Nacional de Cancerologia de Mexicolead sponsor

Mapped research locations

Mexico CityMexico City, Mexico1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04338867 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.